Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (951-960 of 1,142) with videos related to

Pageof 115
Sort By:
Plos Pathogens|February 1, 2024
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation in vitro and in vivoCarolin M Lieber, Hae-Ji Kang, Megha Aggarwal, et al.
Schizophrenia Research|July 12, 2016
The role of the ITIH3 rs2535629 variant in antipsychotic responseE J Brandl, T A Lett, N I Chowdhury, et al.
Neuroscience Letters|July 26, 2005
Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesiaTakahiro Shinkai, Vincenzo De Luca, Rudi Hwang, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation <i>in vitro</i> and <i>in vivo</i>Carolin M Lieber, Hae-Ji Kang, Megha Aggarwal, et al.
Blood Advances|July 5, 2023
Management and outcome of COVID-19 in CTLA-4 insufficiencySebastian Ochoa, Michael S Abers, Lindsey B Rosen, et al.
Neuroscience|April 28, 2009
Developmental regulation of neural cell adhesion molecule in human prefrontal cortexE T Cox, L H Brennaman, K L Gable, et al.
Biological Psychiatry|July 31, 2009
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness studyJonathan M Meyer, Joseph P McEvoy, Vicki G Davis, et al.
Psychiatric Services (Washington, D.C.)|July 28, 2006
Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
The American Journal of Psychiatry|July 20, 2011
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)T Scott Stroup, Joseph P McEvoy, Kimberly D Ring, et al.
Schizophrenia Bulletin|August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentT Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Pageof 115

Showing results (951-960 of 1,142) with videos related to

Sort By:
Pageof 115
Plos Pathogens|February 1, 2024
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation in vitro and in vivoCarolin M Lieber, Hae-Ji Kang, Megha Aggarwal, et al.
Schizophrenia Research|July 12, 2016
The role of the ITIH3 rs2535629 variant in antipsychotic responseE J Brandl, T A Lett, N I Chowdhury, et al.
Neuroscience Letters|July 26, 2005
Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesiaTakahiro Shinkai, Vincenzo De Luca, Rudi Hwang, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation <i>in vitro</i> and <i>in vivo</i>Carolin M Lieber, Hae-Ji Kang, Megha Aggarwal, et al.
Blood Advances|July 5, 2023
Management and outcome of COVID-19 in CTLA-4 insufficiencySebastian Ochoa, Michael S Abers, Lindsey B Rosen, et al.
Neuroscience|April 28, 2009
Developmental regulation of neural cell adhesion molecule in human prefrontal cortexE T Cox, L H Brennaman, K L Gable, et al.
Biological Psychiatry|July 31, 2009
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness studyJonathan M Meyer, Joseph P McEvoy, Vicki G Davis, et al.
Psychiatric Services (Washington, D.C.)|July 28, 2006
Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
The American Journal of Psychiatry|July 20, 2011
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP)T Scott Stroup, Joseph P McEvoy, Kimberly D Ring, et al.
Schizophrenia Bulletin|August 12, 2003
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentT Scott Stroup, Joseph P McEvoy, Marvin S Swartz, et al.
Pageof 115